A Double-Blind Randomized Controlled Trial of Augmentation and Switch Strategies for Refractory Social Anxiety Disorder
Supplemental Material
44_ds001.pdf (469 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×44_ds001.pdf (469 KB)
The authors thank Laura Fischer, B.A., Nannette Herlands, R.N., Maria Kredlow, B.A., Eliora Porter, B.A., and Elizabeth Thompson, Ph.D., from the Massachusetts General Hospital site; Beth Patterson, B.Sc.N., B.Ed., Catherine Mancini, M.D., F.R.C.P.C., Dipen Kalaria, B.Sc.Phm., Jonathan Oakman, Ph.D., and Bill Eickmeier from the McMaster site; and Andrea Letamendi, Ph.D., Orah Stein, M.D., M.P.H., Lakshmi Ravindran, M.D., Jeremy Sable, M.D., and Tali M. Ball from the University of California San Diego site for their invaluable contributions to this study.